Skip to main content

Immunzytologie bei Urotheltumoren

  • Chapter
  • 44 Accesses

Zusammenfassung

Prinzipiell ist der Urin ein ideales Medium zum Nachweis von Urotheltumoren. Dies beruht zum einen auf dem exklusiven Kontakt des Urins mit den ableitenden Harnwegen; die Kontaktdauer zwischen Tumor und Urin kann bis zu mehreren Stunden betragen. Weitere Vorteile liegen darin, daß die Gewinnung einer Probe auf nichtinvasivem Wege erfolgen kann und praktisch unbegrenzte Mengen gewonnen werden können. Urinzytologie und Durchflußzytometrie sind Techniken, die die Vorzüge dieses Mediums nutzen. Vor allem die Urinzytologie hat sich in den vergangenen Jahren in der klinischen Routine bewährt und bildet, neben der Zysturethroskopie, die zweite Säule in der Diagnostik des Transitionalzellkarzinoms (TCC).

Teile der Publikation beruhen auf Untersuchungen, die durch die Deutsche Krebshilfe e. V, den Bundesminister für Forschung und Technologie (01 GA 8701/7) sowie den Minister für Wissenschaft und Forschung des Landes Nordrhein-Westfalen unterstützt wurden.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arndt R, Dürkopf H, Huland H, Donn F, Loening T, Kalthoff H (1987) Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells. J Urol 137: 758–763

    PubMed  CAS  Google Scholar 

  • Bander NH (1987) Monoclonal antibodies: State of art. J Urol 137: 603–612

    PubMed  CAS  Google Scholar 

  • Chicheportiche C, Gazarossian E, Longin, A, Lebreuil G, Hermanowicz M, Richaud C, Beley S, Kaphan S, Fontaniére B, Cotte G, Laurent J-C (1993) Combination of standard cytology and immuncytology with BL2–10D1 monoclonal antibody for monitoring-treated bladder cancer patients. Eur Urol 23: 405–408

    PubMed  CAS  Google Scholar 

  • Chopin DK, deKernion JB, Rosenthal DL, Fahey JL (1985) Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J Urol 134: 260–265

    PubMed  CAS  Google Scholar 

  • Cordon-Cardo C, Reuter VE, Lloyd KO, Sheinfeld J, Fair WR, Old LJ, Melamed MR (1988) Blood group-related antigens in human urothelium: enhanced expression of precursor, Lex and Ley determinants in urothelial carcinoma. Cancer Res 48: 4113–4118

    PubMed  CAS  Google Scholar 

  • Decken K, Schmitz-Dräger BJ, Rohde D, Nakamura S, Ebert T, Ackermann R (1992) Monoclonal antibody Due ABC3 directed against transitional cell carcinoma. I. Production, specificity analysis and preliminary characterization of the antigen. J Urol 147: 235–241

    PubMed  CAS  Google Scholar 

  • Decken K, Held P, Shibayama T, Nakamura S, Ebert T, Schmitz-Dräger B (1994) Monoclonal antibodies directed against urothelial differentiation antigens, (submitted)

    Google Scholar 

  • Dubernard JM, Devonec M, Amiel J, Bouvier R, Fontaniere B, Faucon M (1982) Correlation between cytology and cystoscopy in the follow-up of patients with bladder tumors. Eur Urol 8: 5–8

    PubMed  CAS  Google Scholar 

  • Grossman HB (1983) Hybridoma antibodies reactive with human bladder carcinoma cell surface antigens. J Urol 130: 610–614

    PubMed  CAS  Google Scholar 

  • Hijazi A, Devonec M, Bouvier R, Revillard J-P (1989) Flow cytometry study of cytokeratin 18 expression according to tumor grade and deoxyribonucleic acid content in human bladder tumors. J Urol 141: 522–526

    PubMed  CAS  Google Scholar 

  • Huland E, Huland H, Arndt R, Baisch H, Klöppel G (1988) Urindiagnostik oberflächlicher Harnblasentumoren durch Zytologie, Immunzytologie und Flowzytometrie: Ergebnisse einer prospektiven vergleichenden Studie an 104 Patienten. Akt Urol 19: 13–17

    Article  Google Scholar 

  • Huland E, Huland H, Schneider AW (1990) Quantitative immunocytology in the management of patients with superficial bladder carcinoma. I. A marker to identify patients who do not require prophylaxis. J Urol 144: 637–640

    PubMed  CAS  Google Scholar 

  • Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM, Schmitz-Dräger BJ (1991) Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder. J Urol 146: 1631–1636

    PubMed  CAS  Google Scholar 

  • Huland H, Arndt R, Huland E, Loening TE, Steffens M (1987) Monoclonal antibody 486P3/12: a valuable bladder carcinoma marker for immunocytology. J Urol 137: 654–659

    PubMed  CAS  Google Scholar 

  • Itzkowitz SH, Yuan M, Fukushi Y, Palekar A, Phelps PC, Shamsuddin AM, Trump BF, Hakomori S, Kim YS (1986) Lewisx-antigen expression in human malignant and nonmalignant colonic tissues. Cancer Res 46: 2627–2632

    PubMed  CAS  Google Scholar 

  • Klän R, Huland E, Baisch H, Huland H (1991) Sensitivity of urinary quantitative immunocytology with monoclonal antibody 486P3/12 in 241 unselected patients with bladder carcinoma. J Urol 145: 495–497

    PubMed  Google Scholar 

  • Köhler G, Milstein C (1975) Continous culture of fused cells secreting antibody of predefined specificity. Nature (London) 256: 495–497

    Article  Google Scholar 

  • Koss LG, Deitch D, Ramanathan R, Sherman AB (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29: 810–816

    PubMed  CAS  Google Scholar 

  • Longin A, Hijazi A, Berger-Dutrieux N, Escourrou G, Bouvier R, Richer G, Mironneau I, Frontaniére B, Devonec M, Laurent JC (1989) A monoclonal antibody (BL2–10D1) reacting with a bladder-cancer associated antigen. Int J Cancer 43: 183–189

    Article  PubMed  CAS  Google Scholar 

  • Longin A, Fontaniére B, Berger-Dutrieux N, Devonec M, Laurent J-C (1990) A useful monoclonal antibody (BL2–10D1) to identify tumor cells in urine cytology. Cancer 65: 1412–1417

    Article  PubMed  CAS  Google Scholar 

  • Rettig WJ, Cordon-Cardo C, Ng JS, Oettgen HF, Old LJ, Lloyd KO (1985) Heigh-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res 45: 815–822

    PubMed  CAS  Google Scholar 

  • Schmitz-Dräger BJ, Rohde D, Peschkes C, Ebert T, Ackermann R (1988) Monoklonale Antikörper gegen Harnblasenkarzinome — ein Beitrag zur Verbesserung der Diagnostik? Akt Urol 19: 117–123

    Article  Google Scholar 

  • Schmitz-Dräger BJ, Nakamura S, Decken K, Pfitzer P, Rottmann-Ickler C, Ebert T, Ackermann R (1991) Monoclonal antibody Due ABC3 directed against transitional cell carcinoma. II. Prospective trial on the diagnostic value of immunocytology using monoclonal antibody Due ABC3. J Urol 146: 1521–1524

    PubMed  Google Scholar 

  • Schmitz-Dräger BJ, Gerke R, Strich WE, Decken K, Ebert T (1994) Filter-Immunzytologie (FLIC) — Ein neuer Test zum Nachweis antigener Veränderungen auf Urothelzellen. In: Jonas U (Hrsg) Jahrbuch der Urologie 1994, 147–149

    Google Scholar 

  • Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, Sogani PC, Herr HW, Whitmore WF, Cordon-Cardo C (1990) Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J Urol 143: 285–288

    PubMed  CAS  Google Scholar 

  • Shibayama T, Decken K, Bojar H, Severin M, Ebert T, Ackermann R, Schmitz-Dräger BJ (1994) Untersuchungen zur antikörpergestützten Zweiparameter-Durchflußzytometrie in der Diagnostik von Urotheltumoren. Akt Urol 25: 237–242

    Article  Google Scholar 

  • Walker KZ, Russell PJ, Kingsley EA, Philips J, Raghavan D (1989) Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay. J Urol 142: 1578–1583

    PubMed  CAS  Google Scholar 

  • Zein T, Wajsman Z, Englander LS, Gamarra M, Lopez C, Huben RP, Pontes JE (1984) Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol 132: 670–671

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmitz-Dräger, B.J. (1995). Immunzytologie bei Urotheltumoren. In: Urinzytologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10722-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10722-5_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10723-2

  • Online ISBN: 978-3-662-10722-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics